Brian Wiley
Senior Vice President of Corporate Development & StrategyMr. Brian Wiley is Executive Director of The Sage Group, Inc. Mr. Wiley is Senior Vice President of Corporate Development & Strategy of Aprea Therapeutics AB since November 2023. Mr. Brian Wiley served as Chief Business Officer of Portage Biotech Inc. since February 15, 2022. He served as the Chief Commercial Officer of NewLink Genetics Corporation since 2015. Mr. Wiley served as Vice President of Business Development at NewLink Genetics Corporation from January 2013 to 2015. Mr. Wiley served as Senior Director of Marketing and Business Planning at Gloucester Pharmaceuticals, Inc. since August 2005. He founded Boston BioConsulting, LLC, a consulting firm. At Millennium Pharmaceuticals, he served as an Associate Director of Market Planning and Development and focused on strategic and pre-market planning for Velcade in emerging indications. Mr. Wiley's previous experience includes a diverse 12-year tenure at Aventis Pharmaceuticals (now Sanofi-Aventis), including management positions in marketing, national accounts & sales. He also serves at Celgene. Mr. Wiley received a B.A. in marketing from The Pennsylvania State University and completed graduate level coursework at the University of New Mexico.
Positions
- Company NameAprea Therapeutics, Inc.Stock CodeAPREPositionSenior Vice President of Corporate Development & StrategyColleagues
- OGOren GiladCo-Founder, CEO, President & Director
- RPRichard PetersIndependent Chairperson of the Board
- JPJohn P. HamillSenior VP, CFO, Principal Accounting Officer & Secretary
- LBLars B. AbrahmsenSenior VP & Chief Scientific Officer
- MAMichel AfarganHead of Pharmacology Development
- MJMichael J. GrissingerIndependent Director
- JBJohn B. HennemanIndependent Director
- RPRifat PamukcuIndependent Director
